These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11980952)

  • 1. Comparative analysis of titers of antibody against measles virus in sera of vaccinated and naturally infected Japanese individuals of different age groups.
    Itoh M; Okuno Y; Hotta H
    J Clin Microbiol; 2002 May; 40(5):1733-8. PubMed ID: 11980952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of recent measles virus wild-type isolates to antibody-mediated neutralization by vaccinees with antibody.
    Klingele M; Hartter HK; Adu F; Ammerlaan W; Ikusika W; Muller CP
    J Med Virol; 2000 Sep; 62(1):91-8. PubMed ID: 10935994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of antibodies against measles antigen in institutionalized patients with severe motor and intellectual disability].
    Machida Y; Yamamoto J; Yano Y; Yano T
    Kansenshogaku Zasshi; 2008 Jul; 82(4):328-34. PubMed ID: 18697485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of neutralizing antibody titers against outbreak-associated measles genotypes (D4, H1 and B3) in Iran.
    Fatemi Nasab GS; Salimi V; Abbasi S; Adjami Nezhad Fard F; Mokhtari Azad T
    Pathog Dis; 2016 Nov; 74(8):. PubMed ID: 27777263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of measles virus from a naturally-immune, asymptomatically re-infected individual.
    Vardas E; Kreis S
    J Clin Virol; 1999 Aug; 13(3):173-9. PubMed ID: 10443793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age.
    Paunio M; Hedman K; Davidkin I; Valle M; Heinonen OP; Leinikki P; Salmi A; Peltola H
    Epidemiol Infect; 2000 Apr; 124(2):263-71. PubMed ID: 10813152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies?
    Santibanez S; Niewiesk S; Heider A; Schneider-Schaulies J; Berbers GAM; Zimmermann A; Halenius A; Wolbert A; Deitemeier I; Tischer A; Hengel H
    J Gen Virol; 2005 Feb; 86(Pt 2):365-374. PubMed ID: 15659756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of viral specific CD4 T cells to in vitro stimulation with vaccine and wild measles virus strains in vaccinated and naturally infected subjects.
    Cześcik A; Dunal-Szczepaniak M; Trzcińska A; Siennicka J
    Pol J Microbiol; 2014; 63(2):203-9. PubMed ID: 25115114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simplified immunoassay based on measles virus recombinant hemagglutinin protein for testing the immune status of vaccinees.
    Bouche F; Ammerlaan W; Fournier P; Schneider F; Muller CP
    J Virol Methods; 1998 Sep; 74(1):77-87. PubMed ID: 9763131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
    Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
    Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity.
    Bouche F; Ammerlaan W; Berthet F; Houard S; Schneider F; Muller CP
    J Clin Microbiol; 1998 Mar; 36(3):721-6. PubMed ID: 9508302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles vaccine potency and sero-conversion rates among infants receiving measles immunization in Ilorin, Kwara State, Nigeria.
    Fowotade A; Okonko IO; Nwabuisi C; Bakare RA; Fadeyi A; Adu FD
    J Immunoassay Immunochem; 2015; 36(2):195-209. PubMed ID: 24825255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
    Tischer A; Gerike E
    Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of measles virus-specific antibodies with antibody-dependent cellular cytotoxicity and neutralizing functions.
    Forthal DN; Landucci G; Katz J; Tilles JG
    J Infect Dis; 1993 Oct; 168(4):1020-3. PubMed ID: 8376813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
    Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
    Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles cases in highly vaccinated population of Novosibirsk, Russia, 2000-2005.
    Atrasheuskaya AV; Kulak MV; Neverov AA; Rubin S; Ignatyev GM
    Vaccine; 2008 Apr; 26(17):2111-8. PubMed ID: 18343536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of interleukin-2 (IL-2) receptor alpha and CD45RO antigen on T-lymphocytes cultured with measles virus antigens, compared with humoral immunity in measles vaccinees.
    Toyoda M; Ihara T; Nakano T; Ito M; Kamiya H
    Vaccine; 1999 Mar; 17(11-12):1369-75. PubMed ID: 10195772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of immunoglobulin G subclass profiles induced by measles virus in vaccinated and naturally infected individuals.
    Isa MB; Martínez L; Giordano M; Passeggi C; de Wolff MC; Nates S
    Clin Diagn Lab Immunol; 2002 May; 9(3):693-7. PubMed ID: 11986279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of measles neutralizing antibody related to vaccine and natural infection acquired before HIV infection.
    Isa MB; Pavan JV; Sicilia Don P; Grutadauria S; Martinez LC; Giordano MO; Masachessi G; Barril PA; Nates SV
    Epidemiol Infect; 2014 Aug; 142(8):1708-12. PubMed ID: 24139476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroepidemiological study on prevalence of measles antibodies in Urawa City.
    Tsuji A; Tanioku Y; Nakayama T
    Keio J Med; 1998 Dec; 47(4):209-11. PubMed ID: 9884515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.